Aristotle University Of Thessaloniki (AUTH)
Ανίχνευση της Ε7 ογκοπρωτεΐνης και του DNA του ιού των ανθρωπίνων θηλωμάτων ως μεθόδων δευτερογενούς πρόληψης του καρκίνου του τραχήλου της μήτρας
Abstract
dc:descriptionThe presented thesis aimed to the development and initial clinical assessment of a novel assay for the detection of E7 HPV protein, which could serve as a method for the triage of HPV positive women to colposcopy. Women aged 30-60 years old were recruited and subjected to cervicovaginal sampling. Each sample was tested in terms of liquid-based cytology (LBC) and for the detection of high-risk (hr) HPV DNA using Multiplex Genotyping (MPG). Women positive for either of the two were referred for colposcopy, and when needed biopsy. A fraction of this female population was tested for E7 HPV protein, using five different assays (sandwich ELISA), corresponding to different combinations of HPV types, namely: recomWell HPV 16/18/45 KJhigh, recomWell HPV 39/51/56/59, recomWell HPV 16/31/33/35/52/58, recomWell HPV HR screen and recomWell HPV 16/18/45 KJlow. Diagnostic accuracy analysis was conducted, firstly, concerning primary screening on 1,723/1,762 women initially recruited. For this fraction of the population, hrHPV and HPV16/18 prevalence had been 17.7% and 9,6% respectively. The LBC result had been Atypical Squamous Cells of Undetermined Significance or worse (ASCUS+) in 7.6%. Cervical Intraepithelial Neoplasia grade 2 or worse (CIN2+) was detected in 28 cases (1.6%). The sensitivity of LBC and HPV DNA test for the detection of CIN2+ was 50.0% and 100.0% and the specificity was 94,49% and 85,49% respectively. The approach according to which women positive for HPV16/18 were referred to colposcopy and women positive for other hrHPVs, except HPV16/18, were referred to colposcopy only in case of positive LBC presented sensitivity 78,57% and positive predictive value (PPV) 13.17%. The analysis concerning the E7 testing for the triage of hrHPV positive women was conducted on 1,473/1,723 women, for whom there had been E7 tests results. Among HPV16/18 positive women there had been 16 cases of CIN2+. Performing no triage for HPV16/18 positive women to colposcopy yielded sensitivity 100.0%, PPV 11.11%, whereas the number of colposcopies to detect one case of CIN2+ was 9.0. The sensitivity of the E7 HPV protein detection as a method for the triage of HPV16/18 positive women to colposcopy was 75.0-100.0%, PPV was 16.86-26.08%, and the number of colposcopies to detect one CIN2+ case was 3.83-5.93, depending on the particular E7 test. Cytology, as a method of triage of hrHPV (non 16/18) positive women, a group including 11 CIN2+ cases, to colposcopy, presented sensitivity 45.45%, PPV 27.77%, whereas the number of colposcopies to detect one CIN2+ case was 3.6. The respective values of these indices for the detection of E7 protein was 72.72-100.0%, 16.32-25.0% and 4.0-6.12%, depending on the particular E7 test. As a conclusion, the results of the presented thesis support the use of HPV DNA testing with HPV16/18 genotyping and cytology for the hrHPV (non 16/18) positive women, as a method of primary cervical cancer screening. Moreover, the results support the use of E7 HPV detection tests for the triage of HPV16/18 positive women to colposcopy compared to no triage, and, also, for hrHPV (non 16/18) positive women compared to cytology.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzistamatiou, Kimon
- Χατζησταματίου, Κίμων
Subjects
dc:subject × 14- Πρόληψη καρκίνου τραχήλου μήτρας
- Ιός των ανθρωπίνων θηλωμάτων
- Ε7 πρωτεΐνη
- Προκαρκινική βλάβη τραχήλου μήτρας
- Cervical cancer prevention
- Human Papillomavirus (HPV)
- E7 protein
- Precancerous cervical lesion
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42608